Mr. Clark Kent reports

CHROMEDX ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING AND NAME CHANGE

ChroMedX Corp. has released the results of the annual general meeting held on June 29, 2018. All matters presented to the shareholders were approved including the change of the company's name to Relay Medical Corp.

In accordance with the company's expansion into an integrated medtech accelerator/incubator, as described in its press release of June 19, 2018, the company has changed its name from ChroMedX Corp. to Relay Medical Corp.

It is anticipated that the common shares of the company will commence trading on the Canadian Securities Exchange under its new name, new ticker symbol RELA and Cusip No. 75943L105 (ISIN: CA75943L1058), on or about July 9, 2018.

About ChroMedX Corp.

ChroMedX is a medical technology company that identifies, acquires and develops medical technology opportunities for precommercial acquisitions in the health-tech marketplace.

HemoPalm, the company's lead product, is the only hand-held blood analysis system licensed to combine blood gas and electrolyte sensors with full co-oximetry on one single-use microfluidic cartridge.

ChroMedX technologies are protected by the company's issued and pending portfolio of patents.

We seek Safe Harbor.